Table 5

Availability of a matched sibling donor in donor versus no donor trials

TrialTotalSibling donorSibling no donorNo siblingsNot known if siblings, no donorAll no donor
MRC UKALLXA2113447 (35%)68 (51%)19 (14%)87 (65%)
PMH 92237034 (49%)23 (33%)13 (19%)36 (51%)
JALSG-ALL932412932 (25%)97 (75%)97 (75%)
GRAALL 20032513244 (33%)88 (67%)88 (67%)
HOVON 18 ALL279436 (38%)52 (55%)6 (6%)58 (62%)
GOELAL022812833 (26%)95 (74%)95 (74%)
NILG ALL08/96294518 (40%)27 (60%)27 (60%)
HOVON 37 ALL2716054 (34%)84 (53%)22 (14%)106 (66%)
EORTC 068611122067 (30%)118 (54%)34 (15%)1 (0%)153 (70%)
UKALLXII/E2993141193453 (38%)614 (51%)126 (11%)740 (62%)
PETHEMA ALL-931515470 (45%)84 (55%)84 (55%)
LALA-9416290116 (40%)118 (41%)43 (15%)13 (4%)174 (60%)
EORTC ALL-4/069511721393 (44%)95 (45%)25 (12%)120 (56%)
  • Ph+ patients have been excluded.